GSK short interest
GSK plc · Healthcare · Drug Manufacturers - General · settlement date 2026-09-30
| Shares short | 14,797,116 |
|---|---|
| Change vs prior report | 145,033 (+1.0%) |
| Change over six months | -7.9% |
| Days to cover | 4.14 (sector: 3.78) |
| Average daily volume | 3,575,768 |
| Rank in Healthcare | #506 of 922 by days to cover |
GSK short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 14,797,116 | +1.0% | 4.14 | 3,575,768 |
| 2026-09-15 | 14,652,083 | +8.2% | 5.51 | 2,658,073 |
| 2026-08-31 | 13,546,612 | -8.3% | 4.78 | 2,831,355 |
| 2026-08-14 | 14,778,190 | +1.8% | 4.46 | 3,317,155 |
| 2026-07-31 | 14,516,962 | +5.5% | 2.56 | 5,678,730 |
| 2026-07-15 | 13,759,806 | +7.9% | 4.45 | 3,093,122 |
| 2026-06-30 | 12,755,267 | +51.9% | 3.31 | 3,847,846 |
| 2026-06-15 | 8,398,074 | -14.0% | 1.96 | 4,276,007 |
| 2026-05-29 | 9,768,845 | -28.0% | 3.17 | 3,084,859 |
| 2026-05-15 | 13,570,360 | +2.5% | 3.70 | 3,669,331 |
| 2026-04-30 | 13,234,954 | -14.3% | 2.80 | 4,723,763 |
| 2026-04-15 | 15,452,246 | -3.8% | 3.96 | 3,899,884 |
| 2026-03-31 | 16,061,751 | +29.7% | 3.59 | 4,478,287 |
| 2026-03-13 | 12,381,329 | +14.6% | 2.44 | 5,069,650 |
| 2026-02-27 | 10,805,377 | -17.3% | 1.85 | 5,843,563 |
| 2026-02-13 | 13,069,554 | -26.2% | 1.64 | 7,954,005 |
| 2026-01-30 | 17,722,127 | +1.0% | 3.01 | 5,885,997 |
| 2026-01-15 | 17,551,492 | +17.8% | 3.92 | 4,478,931 |
| 2025-12-31 | 14,906,130 | +32.8% | 5.70 | 2,617,064 |
| 2025-12-15 | 11,227,595 | +3.4% | 3.09 | 3,630,450 |
| 2025-11-28 | 10,855,839 | -13.5% | 2.22 | 4,896,602 |
| 2025-11-14 | 12,554,953 | -12.2% | 2.82 | 4,455,480 |
| 2025-10-31 | 14,297,157 | +7.2% | 2.25 | 6,356,262 |
| 2025-10-15 | 13,334,110 | +6.9% | 1.96 | 6,818,719 |
| 2025-09-30 | 12,475,979 | +13.7% | 2.69 | 4,637,696 |
import finzdata as yf
yf.Ticker("GSK").short_interest # every report since 2017
yf.Client().short_interest(["GSK"], start="2018-01-01")Healthcare short interest · GSK price history · Who owns GSK · All short interest